Web11 de abr. de 2024 · The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.03). The firm had revenue of $100.23 million for the quarter, compared to ... WebOnconova Therapeutics, Inc. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 …
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Web$ONTX PT 1.90-2 Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The … WebOnconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase ... how do new balance 574 fit
Onconova Therapeutics (ONTX) Earnings Date & Reports
WebOnconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? WebFind the latest Earnings Report Date for Onconova Therapeutics, Inc. Common Stock (ONTX) at Nasdaq.com. Onconova Therapeutics, Inc. Common Stock (ONTX) Earnings Report Date Nasdaq Skip to main ... WebDespite a 2.38% increase in earnings, the company posted a loss of $4.02 million. Press releases. From Benzinga Pro Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2024. ... Pa., Sept. 22, 2024 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), ... how much protein in 1 string cheese